Loading patent…
AssigneeFresenius Kabi Deutschland GmbH
InventorsKarin Platenkamp, Craig L. Sandford, Koos L. Hakvoort
Estimating the term…
A container for blood or a blood component is provided, the container comprising one or more container walls defining an interior chamber, the container walls comprising one or more layers, the layers comprising or consisting of a composition comprising one or more polymeric materials and at least one extractable agent selected from the group consisting of a terephthalate ester, a cyclohexane dicarboxylic acid ester, a citrate ester, and a polyol ester, wherein the container further comprises one or more additional components, wherein the container comprises less than about 3% (w/w) of di-2-ethylhexyl phthalate (DEHP), preferably wherein the container comprises less than about 3% (w/w) of phthalates. Thereby, improved blood products are provided in which the DEHP or overall phthalate content is reduced.
A container for blood or a blood component, the container comprising one or more container walls defining an interior chamber, the container walls comprising one or more layers, the one or more layers comprising a composition comprising one or more polymeric materials and a blend of extractable agents including a first extractable agent and a second extractable agent, wherein the first extractable agent comprises a cyclohexane dicarboxylic acid ester and the second extractable agent is selected from the group consisting of a terephthalate ester, a citrate ester, and a polyol ester, wherein the cyclohexane dicarboxylic acid ester comprises about 40-90% (w/w) of the total weight of the first and second extractable agents and the second extractable agent comprises about 10-60% (w/w) of the total weight of the first and second extractable agents, and wherein the container comprises less than about 3% (w/w) of phthalates, including di-2-ethylhexyl phthalate (DEHP).
(canceled)
A system component for a system for blood or blood component collection, processing, storage and/or transfusion, the system component comprising a composition comprising one or more polymeric materials and a blend of extractable agents including a first extractable agent and a second extractable agent, wherein the first extractable agent comprises a cyclohexane dicraboxylic acid ester and the second extractable agent is selected from the group consisting of a terephthalate ester, a citrate ester, and a polyol ester, wherein the system component comprises less than about 3% (w/w) of phthalates including DEHP.
(canceled)
A system for blood or blood component collection, processing, storage and/or transfusion, the system comprising at least one system component comprising a composition comprising one or more polymeric materials and a blend of extractable agents including a first extractable agent and a second extractable agent, wherein the first extractable agent comprises a cyclohexane dicarboxylic acid ester and the second extractable agent is selected from the group consisting of a terephthalate ester, a citrate ester, and a polyol ester, wherein the cyclohexane dicarboxylic acid ester comprises about 40-90% (w/w) of the total weight of the first and second extractable agents and the second extractable agent comprises about 10-60% (w/w) of the total weight of the first and second extractable agents, and, wherein the system comprises less than about 3% (w/w) of phthalates, including di-2-ethylhexyl phthalate.
Dependencies are inferred from the claim text.